Lacosamide Crescent (Lacosamide)

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neurons, which stabilizes hyper‑excitable membranes and reduces the likelihood of repetitive firing that leads to seizures.

The specific dose and titration schedule are determined by the prescribing clinician based on the patient’s age, weight, renal function, and response to therapy. Patients should follow the prescriber’s instructions exactly.

The safety of lacosamide in pregnancy and lactation has not been fully established. Healthcare providers must weigh potential benefits against possible risks and discuss options with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation—differs from many traditional antiepileptics that target fast inactivation. This can provide complementary seizure control when combined with other agents, and it is generally well tolerated compared with some older drugs that have broader side‑effect profiles.

Lacosamide Crescent should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water and follow the dosing schedule provided by the healthcare professional.

Serious risks include cardiac arrhythmias, especially in patients with pre‑existing conduction disorders, and rare severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience chest pain, irregular heartbeat, or extensive rash.

Patients with known hypersensitivity to lacosamide or any of its excipients should avoid the drug. Caution is also advised for individuals with significant cardiac conduction abnormalities, severe renal or hepatic impairment, unless a prescriber determines the benefits outweigh the risks.